IPC2026 was an enriching experience filled with insightful discussions, new perspectives, and valuable connections
NICE guidance recommends regular review of patients taking GLP-1 agonists, typically every 3-6 months, to assess treatment response, side effects, and ongoing appropriateness of therapy
Drug-induced weight gain
doi: 10.1001/jamapsychiatry.2024.4789 l Clinical observation and some preliminary studies suggest the GLP-1 medication semaglutidebetter known by brand names like Ozempic, Mounjaro, and Wegovycan reduce cravings and help individuals with alcohol use disorder reduce or stop drinking
BPC-157 + NAD+ BPC-157 accelerates tissue repair by upregulating growth factor signaling (VEGF, EGF), promoting angiogenesis, and modulating nitric oxide pathways
For patients with type 2 diabetes, HbA1c levels are closely tracked to adjust any concurrent diabetes medications (like insulin or sulfonylureas) to prevent hypoglycemia